Delivery Order SPE2DB20D3303-SPE2DB26FY1E1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,720.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 10 mg chewable tablets (100-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,149.78 to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate 5 mg chewable formulation, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of methylphenidate 5 mg chewable tablets (100-count bottles) with a contract ceiling value of $1,734.28. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed price contract valued at $3,736.67. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,038.80 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100-count units). This competitive, non-set-aside contract was awarded on September 25, 2025, with completion scheduled for September 26, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,928.65 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100-count package) on October 20, 2025, with completion targeted for October 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and supports pharmaceutical supply to federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units under a firm fixed-price contract valued at $1,146.08. This non-set-aside award was executed on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate HCL chewable tablets 5mg under a firm fixed-price arrangement. The contract, valued at $6,183.26, was competitively awarded without set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.56 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed-price contract. The delivery order was executed on August 25, 2025, with an ultimate completion date of August 26, 2025, and is classified as a non-set-aside competitive award. Performance will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,992.32 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY1E1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,114.74 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100-count units) with a completion date of October 24, 2025. This competitive contract award carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. The contractor's extensive federal contract portfolio demonstrates its capability to meet varied federal medical supply requirements through open competition, with the DLA planning future Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/23/25 |